Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Interest Income Other
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The source filing: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026.
- Filed
- Mar 2, 2026, 7:02 AM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-084144
| Line item | For the Year Ended December 31, 2025 | For the Year Ended December 31, 2024 | For the Year Ended December 31, 2023 |
|---|---|---|---|
| (Gain) loss on debt extinguishment | (16,862) | — | 387,329 |
| Loss (gain) on strategic investments, net | 15,914 | 2,785 | (1,527) |
| Interest expense | 38,140 | 18,391 | 22,010 |
| Interest income | (30,763) | (30,635) | (36,257) |
| Income tax expense | 11,185 | 25,535 | 15,879 |
| Depreciation and amortization expense | 44,521 | 37,724 | 44,397 |
| Stock-based compensation expense | 123,396 | 184,300 | 182,514 |
| Gain from sale of Priority Review Voucher | — | — | (102,000) |
Item 16. Form 10-K Summary.
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — interest income other?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — interest income other of $7.69M in Q4 2025.
- How has Sarepta Therapeutics, Inc.'s business segments — interest income other changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — interest income other increased by 0.4% year-over-year, from $7.66M to $7.69M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — interest income other?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — interest income other has grown at a 23.1% compound annual growth rate (CAGR), from $16.49M to $30.76M.
- What does business segments — interest income other mean?
- Other interest-related income streams generated by the segment that are not classified as core operating revenue. This includes interest earned on various financial assets or specific contractual arrangements. It contributes to the segment's non-operating income and overall liquidity profile.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — interest income other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude